Navigation Links
WuXi PharmaTech Announces Second-Quarter 2010 Results
Date:8/1/2010

(144) 11% (257) (94) 173% Income tax expenses 2,923 2,069 41% 5,122 3,952 30% EBITDA 23,373 22,231 5% 47,371 40,906 16% Adjustments Share-based compensation 2,748 2,659 3% 5,069 4,658 9% Mark-to-market gains (losses) from foreign-currency forward contracts (200) 401 * 416 (2,219) * Non-recurring deal costs 2,933 -- * 2,933 * Impairment charge from discontinued operations -- -- -- -- * Adjusted EBITDA 28,854 25,291 14% 55,789 43,345 29% Income attributable to holders of ADS (Non-GAAP): Basic 19,907 17,813 12% 38,214 32,015 19% Diluted 19,907 17,813 12% 38,214 32,015 19% Basic earnings per ADS (Non-GAAP) 0.29 0.26 9% 0.55 0.47 16% Diluted earnings per ADS (Non-GAAP) 0.27 0.24 10% 0.51 0.44 18% Weighted average ADS outstanding - basic 69,416,476 67,944,436 69,246,669 67,469,104 Weighted average ADS outstanding - diluted 74,591,847 73,152,798 74,465,668 73,356,170 * Not meaningful WUXI PHARMATECH (CAYMAN) INC. REVENUE BREAKDOWN (in thousands of U.S. dollars) Three Months Ended Six Months Ended June 30, June 30, 2010 2009 % 2010 2009 % Net revenues: China-based Laboratory Services 52,673 44,810 18% 102,645 86,458 19% U.S.-based Laboratory Services 19,908 16,679 19% 36,934 31,626 17% Subtotal
'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
2. WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
3. WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer
4. WuXi PharmaTech Announces First-Quarter 2010 Results
5. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
6. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
7. WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
8. WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
9. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
10. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
11. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014  Medical Science Liaisons play ... key link between the medical device industry and key ... in the coming years as the device industry relies ... According to research by benchmarking firm, Best Practices, LLC, ... an important edge is by harnessing new technology to ...
(Date:12/22/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/h3xm6q/us ... Self-monitoring Blood Glucose Market" report to their offering. ... This market insight focuses on the developments in the ... States . Reimbursement analysis and the effects of ... more than 73 SMBG meters have been performed, based ...
(Date:12/22/2014)... -- Cyberonics, Inc. (NASDAQ: CYBX ), a global ... epilepsy, today announced it will participate in the 33 rd ... 2015, in San Francisco . ... will speak at 11:00 AM Pacific Time.  A live audio ... the Investor Relations link on the Cyberonics home page at ...
Breaking Medicine Technology:Role of Medical Science Liaisons Evolving in Medical Device Sector 2US Self-monitoring Blood Glucose Market 2
... September 2 , - CAPRA-2-Data ... Nitec Pharma AG ("Nitec" or "Nitec ... commercialization of,medicines to treat chronic inflammation and pain-related diseases, today,announced ... its,lead product, Lodotra(TM). , The CAPRA-2 ...
... , , , ... Park, Ph. D., Head of Process Sciences at aTyr Pharma, a ... newly emerging class of natural biotherapeutics, will be a featured speaker ... will present his talk "Selecting the Optimal Biotherapeutic Candidate for Development" ...
Cached Medicine Technology:Nitec Pharma Reports Positive and Highly Significant Phase III Results From Capra-2 Study of Lodotra(TM) in RA 2Nitec Pharma Reports Positive and Highly Significant Phase III Results From Capra-2 Study of Lodotra(TM) in RA 3Head of Process Sciences at aTyr Pharma to Speak at Bio Korea 2009 2
(Date:12/25/2014)... The microscopy market is estimated to grow at ... by 2019. Optical microscopy is the largest segment ... segment is expected to show the fastest growth ... nanotechnology, technological advancements, and increasing federal support to ... Full Copy of Report @ http://www.marketsandmarkets.com/Market-Reports/world-microscopy-399.html ...
(Date:12/25/2014)... The click strand woven ... and durability. Today, the business announces a click ... until Jan. 30, 2015. , Click strand woven ... BambooFlooringChina.com is a well-known brand in the bamboo ... find a reliable bamboo flooring supplier. , “We ...
(Date:12/25/2014)... The report “TS-1 (Colorectal Cancer) – Forecast and ... landscape, unmet needs, current pipeline and commercial opportunities in ... which is typically used for treating colorectal cancer. It ... gastric cancer and pancreatic cancer. TS-1 is composed of ... approved in 1999 in Japan for the treatment of ...
(Date:12/25/2014)... “Every three months the trends for ... evening dress will be one of the hottest styles in ... says. Today, the company releases 26 A-line sweetheart evening dresses, ... off. , “We are trying our best to help ... latest designs. Along with affordable prices, we provide discounted delivery ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 Recently, Dylan ... dresses, has excitedly released its collection of discounted prom ... to Percy, a senior spokesman of the company, the ... of this promotion is to expand the UK market. ... in several different colors, lengths, and styles: A-line strapless, ...
Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2
... BRUNSWICK, N.J., March 13 Johnson &,Johnson will ... Health Care,Conference on Thursday, March 20th at the ... Goggins, Worldwide Chairman,Consumer Group will represent the Company ... The webcast will be available to investors ...
... found 10 percent fewer new cases over a decade , , THURSDAY, ... every other day seems to reduce the risk of developing asthma ... of Thorax , essentially mirrors a similar study in which ... the study authors warned that the research was still not ...
... 51, Scores Big at Arnold Classic; Says ... Better, Faster -, PHOENIX, March 13 NutraCea ... bran (SRB), nutrient,research and technology announced today that champion ... (IPF) world,record with a squat lift of 716 pounds ...
... Owing to Safety and Delivery End Points, Drugs from Eli ... According ... from Decision Resources, WALTHAM, Mass., March 13 Decision ... on pharmaceutical and,healthcare issues, finds that a drug,s effect on ...
... FRANCISCO, Calif., March 13 Rigel,Pharmaceuticals, Inc. (Nasdaq: ... chairman and chief executive officer, is scheduled to present,a ... Healthcare,Conference in Miami, Florida on Tuesday, March 18 at ... to participate in a panel discussion titled,"Biotech Models: Should ...
... Neurochem,(International) Limited (Neurochem), a wholly-owned subsidiary of ... announces that the Company is taking new,initiatives ... its investigational,product candidate, eprodisate (KIACTA(TM)), to obtain ... (AA) amyloidosis. Neurochem,s decision to build,upon its ...
Cached Medicine News:Health News:Aspirin Reduces Asthma Risk Among Older Women 2Health News:New World Record Holder in Powerlifting Credits NutraCea's Unique Rice-Bran-derived Product as his 'Secret Weapon' 2Health News:New World Record Holder in Powerlifting Credits NutraCea's Unique Rice-Bran-derived Product as his 'Secret Weapon' 3Health News:New World Record Holder in Powerlifting Credits NutraCea's Unique Rice-Bran-derived Product as his 'Secret Weapon' 4Health News:Current and Emerging Therapies Have No Advantage Over Pfizer's Lyrica in Their Effect on Patients' Quality of Life in the Treatment of Diabetic Neuropathy 2Health News:Rigel Announces Participation in Upcoming Investor and Partnering Conferences 2Health News:Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis 2Health News:Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis 3Health News:Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis 4
This instrument measures intraocular pressure without,contacting. Alignment is performed semi-automatically....
... The InfusO.R. Pump is a ... aid in the administration of ... anesthetic procedures. It provides for ... muscle relaxants, and vasoactive drugs ...
... The Ipump Pain Management System answers ... environment with one-on-one flexibility. From programming ... puts customizable pain management right where ... system is designed to help each ...
The FLO-GARD 6201 Volumetric Infusion Pump and the FLO-GARD 6301 Dual-Channel Volumetric Infusion Pump are industry standard in standard set infusion pump technology....
Medicine Products: